Singapore Healthtech Faces Funding Shortfall Despite Deal Surge

  • 📰 SBRMagazine
  • ⏱ Reading Time:
  • 16 sec. here
  • 11 min. at publisher
  • 📊 Quality Score:
  • News: 41%
  • Publisher: 51%

Technology News

Singapore,Healthtech,Funding

The healthtech vertical in Singapore received less funding in 2023 despite an increase in the number of deals. On the other hand, the healthcare vertical saw more funding despite fewer deals. Startups are focusing on solving healthcare affordability and availability issues, with investors closely monitoring sub-sectors such as precision medicine, digital therapeutics, and telemedicine.

Singapore healthtech faces funding shortfall despite deal surgeThe healthtech vertical amassed less funding in 2023 despite more deals.

The report added that startups today are stepping up to solve problems related to healthcare affordability and availability. Holmusk led the health tech startup landscape in 2023, securing US$75m in funding from investors, including Health Catalyst Capital, Heritas Capital, Novartis, and Veradigm.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 13. in HEALTH

Health Health Latest News, Health Health Headlines